News
ABC News chief medical correspondent Dr. Tara Narula breaks down what to know about a new study that says Zepbound may be ...
Eli Lilly's tirzepatide leads to 50% more weight loss compared to Novo Nordisk's semaglutide in 72-week study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results